Gregory Russotti

Chief Tech/Sci/R&D Officer at CENTURY THERAPEUTICS, INC.

Net worth: 1 M $ as of 31/05/2024

57 year

Health Technology

Consumer Services

Finance

Gregory Russotti active positions

Companies	Position	Start	End
CENTURY THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/01/2020	-
	Chief Executive Officer	11/04/2023	04/12/2023
	President	11/04/2023	04/12/2023
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Consultant / Advisor	-	-

Companies	Position	Start	End
CELGENE	Corporate Officer/Principal	01/10/2017	31/12/2019

Rensselaer Polytechnic Institute	Graduate Degree
Rutgers State University of New Jersey	Doctorate Degree

International

United States	5
France	2

Operational

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
CENTURY THERAPEUTICS, INC.	Health Technology

Private companies	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Finance

Private companies

Health Technology

Finance